Real world preventative drug management of migraine among Spanish neurologists View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

D. García-Azorin, S. Santos-Lasaosa, A. B. Gago-Veiga, J. Viguera Romero, A. L. Guerrero-Peral

ABSTRACT

BACKGROUND: Many different preventatives have showed efficacy in the treatment of migraine. National guidelines differ in their recommendations and patients' characteristics are usually taken into account in their selection. In Spain, real life use of preventive therapies seems to be heterogeneous. We aimed to evaluate differences in clinical practice and adherence to national guidelines among Spanish neurologists. METHODS: Observational descriptive study. A survey was conducted among neurologists ascribed to the Spanish Society of Neurology. Participants were differentiated in accordance with their dedication to headache disorders. We analysed socio-demographic parameters and evaluated 43 questions considering migraine management as well as therapeutic choices regarding migraine sub-types and finally, neurologists' personal perception. RESULTS: One hundred fifty-five neurologists participated from 17 different regions, 43.4% of them female and 53.3% under 40 years of age. 34.9% confirmed headache disorders as their main interest. The first choice for preventive therapy in chronic migraine among participants was topiramate (57%) followed by amytriptiline (17.9%) and beta-blockers (14.6%). However in episodic migraine, the preferred options were beta-blockers (47.7%), topiramate (21.5%) and amytriptiline (13.4%). Regarding perceived efficacy, topiramate was considered the best option in chronic migraine (42.7%) followed by onabotulinumtoxinA (25.5%) and amitryptiline (22.4%). Where episodic migraine was concerned, surveyed neurologists perceived topiramate (43.7%) and beta-blockers (30.3%) as the best options. When we evaluated the duration of treatment use with a view to adequate therapeutic response, 43.5% of neurologists preferred 3 months duration and 39.5% were in favour of 6 months duration in episodic migraine. However, considering the preferred duration of treatment use in chronic migraine, 20.4% recommended 3 months, 42.1% preferred 6 months and 12.5% and 22.4% opted for 9 and 12 months respectively. When considering onabotulinumtoxinA therapy, the number of prior therapeutic failures was zero in 7.2% of neurologists, one in 5.9%, two in 44.1%, three in 30.9% and four or more in 11.9%. Following an initial treatment failure with onabotulinumtoxinA, 49% of subjects decided against a second treatment. The number of OnabotA procedures before considering it as ineffective was two in 18.9% of neurologists, three in 70.8% and four in 10.4%. CONCLUSIONS: The initial management of migraine among Spanish Neurologists is in line with most guidelines, where first choice preventative drugs are concerned. The Management of episodic migraine differed from chronic migraine, both in terms of neurologist preference and in their perceived efficacy. More... »

PAGES

19

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s10194-019-0971-6

DOI

http://dx.doi.org/10.1186/s10194-019-0971-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112168755

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30770719


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hospital Cl\u00ednico Universitario de Valladolid", 
          "id": "https://www.grid.ac/institutes/grid.411057.6", 
          "name": [
            "Headache Unit, Neurology Department, Hospital Universitario Cl\u00ednico de Valladolid, Avda. Ram\u00f3n y Cajal 3, 47005, Valladolid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garc\u00eda-Azorin", 
        "givenName": "D.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Cl\u00ednico Universitario Lozano Blesa", 
          "id": "https://www.grid.ac/institutes/grid.411050.1", 
          "name": [
            "Headache Unit. Neurology Departmente, Hospital Cl\u00ednico Universitario Lozano Blesa, Zaragoza, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Santos-Lasaosa", 
        "givenName": "S.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitario de La Princesa", 
          "id": "https://www.grid.ac/institutes/grid.411251.2", 
          "name": [
            "Headache Unit, Neurology Department, Hospital Universitario de la Princesa, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gago-Veiga", 
        "givenName": "A. B.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital Universitario Virgen Macarena", 
          "id": "https://www.grid.ac/institutes/grid.411375.5", 
          "name": [
            "Headache Unit, Neuroscience Department, Hospital Universitario Virgen Macarena, Sevilla, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Viguera Romero", 
        "givenName": "J.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca", 
          "id": "https://www.grid.ac/institutes/grid.452531.4", 
          "name": [
            "Headache Unit, Neurology Department, Hospital Universitario Cl\u00ednico de Valladolid, Avda. Ram\u00f3n y Cajal 3, 47005, Valladolid, Spain", 
            "Institute for Biomedical Research of Salamanca, IBSAL, Salamanca, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guerrero-Peral", 
        "givenName": "A. L.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/j.1526-4610.2006.00684.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003597296"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/14651858.cd010610", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004953196"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0404.2008.01087.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010843611"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.289.1.65", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018257798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1468-2982.2007.01326.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032616389"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1468-2982.2007.01326.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032616389"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nrl.2013.12.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036313562"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0333102410364677", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042093128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0333102410364677", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042093128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0333102410364676", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047073002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0333102410364676", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047073002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1468-2982.1997.1702109.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048401477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1468-2982.1997.1702109.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048401477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.322.7277.19", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049830616"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/14737175.2016.1200973", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050540789"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nrl.2014.04.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053185726"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078047954", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.33588/rn.5003.2009721", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078047954"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s10194-017-0773-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090322309", 
          "https://doi.org/10.1186/s10194-017-0773-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s10194-017-0773-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090322309", 
          "https://doi.org/10.1186/s10194-017-0773-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40259-017-0251-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092592550", 
          "https://doi.org/10.1007/s40259-017-0251-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nrl.2017.09.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092916967"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/ene.13523", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092955480"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3389/fneur.2017.00655", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1093151744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s10194-018-0840-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100820509", 
          "https://doi.org/10.1186/s10194-018-0840-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/head.13302", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103636430"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s10194-018-0898-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106150064", 
          "https://doi.org/10.1186/s10194-018-0898-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s10194-018-0921-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1107254500", 
          "https://doi.org/10.1186/s10194-018-0921-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40263-018-0579-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1107553600", 
          "https://doi.org/10.1007/s40263-018-0579-4"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: Many different preventatives have showed efficacy in the treatment of migraine. National guidelines differ in their recommendations and patients' characteristics are usually taken into account in their selection. In Spain, real life use of preventive therapies seems to be heterogeneous. We aimed to evaluate differences in clinical practice and adherence to national guidelines among Spanish neurologists.\nMETHODS: Observational descriptive study. A survey was conducted among neurologists ascribed to the Spanish Society of Neurology. Participants were differentiated in accordance with their dedication to headache disorders. We analysed socio-demographic parameters and evaluated 43 questions considering migraine management as well as therapeutic choices regarding migraine sub-types and finally, neurologists' personal perception.\nRESULTS: One hundred fifty-five neurologists participated from 17 different regions, 43.4% of them female and 53.3% under 40\u2009years of age. 34.9% confirmed headache disorders as their main interest. The first choice for preventive therapy in chronic migraine among participants was topiramate (57%) followed by amytriptiline (17.9%) and beta-blockers (14.6%). However in episodic migraine, the preferred options were beta-blockers (47.7%), topiramate (21.5%) and amytriptiline (13.4%). Regarding perceived efficacy, topiramate was considered the best option in chronic migraine (42.7%) followed by onabotulinumtoxinA (25.5%) and amitryptiline (22.4%). Where episodic migraine was concerned, surveyed neurologists perceived topiramate (43.7%) and beta-blockers (30.3%) as the best options. When we evaluated the duration of treatment use with a view to adequate therapeutic response, 43.5% of neurologists preferred 3\u2009months duration and 39.5% were in favour of 6\u2009months duration in episodic migraine. However, considering the preferred duration of treatment use in chronic migraine, 20.4% recommended 3\u2009months, 42.1% preferred 6\u2009months and 12.5% and 22.4% opted for 9 and 12\u2009months respectively. When considering onabotulinumtoxinA therapy, the number of prior therapeutic failures was zero in 7.2% of neurologists, one in 5.9%, two in 44.1%, three in 30.9% and four or more in 11.9%. Following an initial treatment failure with onabotulinumtoxinA, 49% of subjects decided against a second treatment. The number of OnabotA procedures before considering it as ineffective was two in 18.9% of neurologists, three in 70.8% and four in 10.4%.\nCONCLUSIONS: The initial management of migraine among Spanish Neurologists is in line with most guidelines, where first choice preventative drugs are concerned. The Management of episodic migraine differed from chronic migraine, both in terms of neurologist preference and in their perceived efficacy.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s10194-019-0971-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1022710", 
        "issn": [
          "1129-2369", 
          "1129-2377"
        ], 
        "name": "The Journal of Headache and Pain", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "20"
      }
    ], 
    "name": "Real world preventative drug management of migraine among Spanish neurologists", 
    "pagination": "19", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "8b0372390f112872a83c7a8ddb25a7582d451e03a20432dedcb74430afda0d08"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30770719"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100940562"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s10194-019-0971-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112168755"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s10194-019-0971-6", 
      "https://app.dimensions.ai/details/publication/pub.1112168755"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:06", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000337_0000000337/records_37559_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs10194-019-0971-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s10194-019-0971-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s10194-019-0971-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s10194-019-0971-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s10194-019-0971-6'


 

This table displays all metadata directly associated to this object as RDF triples.

182 TRIPLES      21 PREDICATES      53 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s10194-019-0971-6 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Nd836275ebe0a44a58a69925a13c17f4a
4 schema:citation sg:pub.10.1007/s40259-017-0251-4
5 sg:pub.10.1007/s40263-018-0579-4
6 sg:pub.10.1186/s10194-017-0773-7
7 sg:pub.10.1186/s10194-018-0840-8
8 sg:pub.10.1186/s10194-018-0898-3
9 sg:pub.10.1186/s10194-018-0921-8
10 https://app.dimensions.ai/details/publication/pub.1078047954
11 https://doi.org/10.1001/jama.289.1.65
12 https://doi.org/10.1002/14651858.cd010610
13 https://doi.org/10.1016/j.nrl.2013.12.010
14 https://doi.org/10.1016/j.nrl.2014.04.005
15 https://doi.org/10.1016/j.nrl.2017.09.008
16 https://doi.org/10.1046/j.1468-2982.1997.1702109.x
17 https://doi.org/10.1080/14737175.2016.1200973
18 https://doi.org/10.1111/ene.13523
19 https://doi.org/10.1111/head.13302
20 https://doi.org/10.1111/j.1468-2982.2007.01326.x
21 https://doi.org/10.1111/j.1526-4610.2006.00684.x
22 https://doi.org/10.1111/j.1600-0404.2008.01087.x
23 https://doi.org/10.1136/bmj.322.7277.19
24 https://doi.org/10.1177/0333102410364676
25 https://doi.org/10.1177/0333102410364677
26 https://doi.org/10.33588/rn.5003.2009721
27 https://doi.org/10.3389/fneur.2017.00655
28 schema:datePublished 2019-12
29 schema:datePublishedReg 2019-12-01
30 schema:description BACKGROUND: Many different preventatives have showed efficacy in the treatment of migraine. National guidelines differ in their recommendations and patients' characteristics are usually taken into account in their selection. In Spain, real life use of preventive therapies seems to be heterogeneous. We aimed to evaluate differences in clinical practice and adherence to national guidelines among Spanish neurologists. METHODS: Observational descriptive study. A survey was conducted among neurologists ascribed to the Spanish Society of Neurology. Participants were differentiated in accordance with their dedication to headache disorders. We analysed socio-demographic parameters and evaluated 43 questions considering migraine management as well as therapeutic choices regarding migraine sub-types and finally, neurologists' personal perception. RESULTS: One hundred fifty-five neurologists participated from 17 different regions, 43.4% of them female and 53.3% under 40 years of age. 34.9% confirmed headache disorders as their main interest. The first choice for preventive therapy in chronic migraine among participants was topiramate (57%) followed by amytriptiline (17.9%) and beta-blockers (14.6%). However in episodic migraine, the preferred options were beta-blockers (47.7%), topiramate (21.5%) and amytriptiline (13.4%). Regarding perceived efficacy, topiramate was considered the best option in chronic migraine (42.7%) followed by onabotulinumtoxinA (25.5%) and amitryptiline (22.4%). Where episodic migraine was concerned, surveyed neurologists perceived topiramate (43.7%) and beta-blockers (30.3%) as the best options. When we evaluated the duration of treatment use with a view to adequate therapeutic response, 43.5% of neurologists preferred 3 months duration and 39.5% were in favour of 6 months duration in episodic migraine. However, considering the preferred duration of treatment use in chronic migraine, 20.4% recommended 3 months, 42.1% preferred 6 months and 12.5% and 22.4% opted for 9 and 12 months respectively. When considering onabotulinumtoxinA therapy, the number of prior therapeutic failures was zero in 7.2% of neurologists, one in 5.9%, two in 44.1%, three in 30.9% and four or more in 11.9%. Following an initial treatment failure with onabotulinumtoxinA, 49% of subjects decided against a second treatment. The number of OnabotA procedures before considering it as ineffective was two in 18.9% of neurologists, three in 70.8% and four in 10.4%. CONCLUSIONS: The initial management of migraine among Spanish Neurologists is in line with most guidelines, where first choice preventative drugs are concerned. The Management of episodic migraine differed from chronic migraine, both in terms of neurologist preference and in their perceived efficacy.
31 schema:genre research_article
32 schema:inLanguage en
33 schema:isAccessibleForFree true
34 schema:isPartOf N6ad3c6bd233b4a7e9b06e87e6615cb47
35 Na5d0b977ec2b435bbc06b23779511a39
36 sg:journal.1022710
37 schema:name Real world preventative drug management of migraine among Spanish neurologists
38 schema:pagination 19
39 schema:productId N05e6858eb79447b99ecb233544bcc403
40 N080e8186e94745248476c26a74e24952
41 N38de5a1a151d4b039b018d9a9e09d27f
42 N4e3d7c5a9ab74e049077d94c1e111eb8
43 Nfcdbecaf087c413ba104d4ffc35bf51c
44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112168755
45 https://doi.org/10.1186/s10194-019-0971-6
46 schema:sdDatePublished 2019-04-11T09:06
47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
48 schema:sdPublisher Ne0fdb4070c394fbab76277be4012dd18
49 schema:url https://link.springer.com/10.1186%2Fs10194-019-0971-6
50 sgo:license sg:explorer/license/
51 sgo:sdDataset articles
52 rdf:type schema:ScholarlyArticle
53 N05e6858eb79447b99ecb233544bcc403 schema:name readcube_id
54 schema:value 8b0372390f112872a83c7a8ddb25a7582d451e03a20432dedcb74430afda0d08
55 rdf:type schema:PropertyValue
56 N080e8186e94745248476c26a74e24952 schema:name doi
57 schema:value 10.1186/s10194-019-0971-6
58 rdf:type schema:PropertyValue
59 N1eeecb671a59454eaa26b2c4fdea4fc9 rdf:first N24d4fb532f8f418c891e3b2c7080f662
60 rdf:rest Ne094a10ef1ea44d3b3f21046cfcaf97c
61 N24d4fb532f8f418c891e3b2c7080f662 schema:affiliation https://www.grid.ac/institutes/grid.411251.2
62 schema:familyName Gago-Veiga
63 schema:givenName A. B.
64 rdf:type schema:Person
65 N38de5a1a151d4b039b018d9a9e09d27f schema:name nlm_unique_id
66 schema:value 100940562
67 rdf:type schema:PropertyValue
68 N404352ebb25d423e99a3f7e10fd9b740 schema:affiliation https://www.grid.ac/institutes/grid.452531.4
69 schema:familyName Guerrero-Peral
70 schema:givenName A. L.
71 rdf:type schema:Person
72 N4e3d7c5a9ab74e049077d94c1e111eb8 schema:name dimensions_id
73 schema:value pub.1112168755
74 rdf:type schema:PropertyValue
75 N56c09efc6d754c86995e418507af1fc3 rdf:first N90ebd219dbe8477a847eb26a8d5b5d0f
76 rdf:rest N1eeecb671a59454eaa26b2c4fdea4fc9
77 N6ad3c6bd233b4a7e9b06e87e6615cb47 schema:issueNumber 1
78 rdf:type schema:PublicationIssue
79 N90ebd219dbe8477a847eb26a8d5b5d0f schema:affiliation https://www.grid.ac/institutes/grid.411050.1
80 schema:familyName Santos-Lasaosa
81 schema:givenName S.
82 rdf:type schema:Person
83 Na5d0b977ec2b435bbc06b23779511a39 schema:volumeNumber 20
84 rdf:type schema:PublicationVolume
85 Na5fef4fc3a0e4d499f00a8a6ba36a164 schema:affiliation https://www.grid.ac/institutes/grid.411057.6
86 schema:familyName García-Azorin
87 schema:givenName D.
88 rdf:type schema:Person
89 Nd836275ebe0a44a58a69925a13c17f4a rdf:first Na5fef4fc3a0e4d499f00a8a6ba36a164
90 rdf:rest N56c09efc6d754c86995e418507af1fc3
91 Ndbfbb4ef4d694dab952e652bd2d469b8 schema:affiliation https://www.grid.ac/institutes/grid.411375.5
92 schema:familyName Viguera Romero
93 schema:givenName J.
94 rdf:type schema:Person
95 Ne094a10ef1ea44d3b3f21046cfcaf97c rdf:first Ndbfbb4ef4d694dab952e652bd2d469b8
96 rdf:rest Ne1e74f6492ea4fa192d77339ccf2ba01
97 Ne0fdb4070c394fbab76277be4012dd18 schema:name Springer Nature - SN SciGraph project
98 rdf:type schema:Organization
99 Ne1e74f6492ea4fa192d77339ccf2ba01 rdf:first N404352ebb25d423e99a3f7e10fd9b740
100 rdf:rest rdf:nil
101 Nfcdbecaf087c413ba104d4ffc35bf51c schema:name pubmed_id
102 schema:value 30770719
103 rdf:type schema:PropertyValue
104 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
105 schema:name Medical and Health Sciences
106 rdf:type schema:DefinedTerm
107 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
108 schema:name Clinical Sciences
109 rdf:type schema:DefinedTerm
110 sg:journal.1022710 schema:issn 1129-2369
111 1129-2377
112 schema:name The Journal of Headache and Pain
113 rdf:type schema:Periodical
114 sg:pub.10.1007/s40259-017-0251-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092592550
115 https://doi.org/10.1007/s40259-017-0251-4
116 rdf:type schema:CreativeWork
117 sg:pub.10.1007/s40263-018-0579-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107553600
118 https://doi.org/10.1007/s40263-018-0579-4
119 rdf:type schema:CreativeWork
120 sg:pub.10.1186/s10194-017-0773-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090322309
121 https://doi.org/10.1186/s10194-017-0773-7
122 rdf:type schema:CreativeWork
123 sg:pub.10.1186/s10194-018-0840-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100820509
124 https://doi.org/10.1186/s10194-018-0840-8
125 rdf:type schema:CreativeWork
126 sg:pub.10.1186/s10194-018-0898-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106150064
127 https://doi.org/10.1186/s10194-018-0898-3
128 rdf:type schema:CreativeWork
129 sg:pub.10.1186/s10194-018-0921-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107254500
130 https://doi.org/10.1186/s10194-018-0921-8
131 rdf:type schema:CreativeWork
132 https://app.dimensions.ai/details/publication/pub.1078047954 schema:CreativeWork
133 https://doi.org/10.1001/jama.289.1.65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018257798
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1002/14651858.cd010610 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004953196
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1016/j.nrl.2013.12.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036313562
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1016/j.nrl.2014.04.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053185726
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1016/j.nrl.2017.09.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092916967
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1046/j.1468-2982.1997.1702109.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1048401477
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1080/14737175.2016.1200973 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050540789
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1111/ene.13523 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092955480
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1111/head.13302 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103636430
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1111/j.1468-2982.2007.01326.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032616389
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1111/j.1526-4610.2006.00684.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1003597296
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1111/j.1600-0404.2008.01087.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010843611
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1136/bmj.322.7277.19 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049830616
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1177/0333102410364676 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047073002
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1177/0333102410364677 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042093128
162 rdf:type schema:CreativeWork
163 https://doi.org/10.33588/rn.5003.2009721 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078047954
164 rdf:type schema:CreativeWork
165 https://doi.org/10.3389/fneur.2017.00655 schema:sameAs https://app.dimensions.ai/details/publication/pub.1093151744
166 rdf:type schema:CreativeWork
167 https://www.grid.ac/institutes/grid.411050.1 schema:alternateName Hospital Clínico Universitario Lozano Blesa
168 schema:name Headache Unit. Neurology Departmente, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
169 rdf:type schema:Organization
170 https://www.grid.ac/institutes/grid.411057.6 schema:alternateName Hospital Clínico Universitario de Valladolid
171 schema:name Headache Unit, Neurology Department, Hospital Universitario Clínico de Valladolid, Avda. Ramón y Cajal 3, 47005, Valladolid, Spain
172 rdf:type schema:Organization
173 https://www.grid.ac/institutes/grid.411251.2 schema:alternateName Hospital Universitario de La Princesa
174 schema:name Headache Unit, Neurology Department, Hospital Universitario de la Princesa, Madrid, Spain
175 rdf:type schema:Organization
176 https://www.grid.ac/institutes/grid.411375.5 schema:alternateName Hospital Universitario Virgen Macarena
177 schema:name Headache Unit, Neuroscience Department, Hospital Universitario Virgen Macarena, Sevilla, Spain
178 rdf:type schema:Organization
179 https://www.grid.ac/institutes/grid.452531.4 schema:alternateName Instituto de Investigación Biomédica de Salamanca
180 schema:name Headache Unit, Neurology Department, Hospital Universitario Clínico de Valladolid, Avda. Ramón y Cajal 3, 47005, Valladolid, Spain
181 Institute for Biomedical Research of Salamanca, IBSAL, Salamanca, Spain
182 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...